Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cell Reports|June 25, 2013
An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progressionJungsun Kim, John P Hoffman, R Katherine Alpaugh, et al.
International Journal of Molecular Sciences|November 14, 2023
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen SequencingSandra V Fernandez, Yin Fei Tan, Shilpa Rao, et al.
British Journal of Cancer|March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
European Urology|January 4, 2022
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell CarcinomaOscar Reig Torras, Akhilesh Mishra, Alana Christie, et al.
Gynecologic Oncology|August 28, 2012
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Heather A Lankes, et al.
JCO Clinical Cancer Informatics|January 25, 2021
Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal CancerWilliam H Ward, Caitlin R Meeker, Elizabeth Handorf, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2019
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell LymphomaStefan K Barta, Jasmine Zain, Alexander W MacFarlane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinomaSteven J Cohen, Linus Ho, Sulabha Ranganathan, et al.
European Urology Oncology|March 14, 2020
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H Hoffman-Censits, Fern Anari, et al.
Clinical Colorectal Cancer|September 2, 2006
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancerSteven J Cohen, R Katherine Alpaugh, Steve Gross, et al.
Pageof 6